Literature DB >> 12964886

Seizures in elderly patients with dementia: epidemiology and management.

Mario Mendez1, Gerald Lim.   

Abstract

Epileptic seizures occur in patients with dementia at a higher prevalence than among healthy elderly individuals. The incidence of seizures among patients with dementia varies with the aetiology of the dementing illness. In patients with Alzheimer's disease (the most common form of dementia), approximately 10-22% have at least one unprovoked seizure. Seizures usually occur in later stages of Alzheimer's disease, on average, > or =6 years into the course of the disease. Seizures in Alzheimer's disease are more likely to occur with early-onset disease, particularly if there is a familial presenilin I mutation. The incidence of seizures in other dementing diseases is less clear. There are special considerations regarding the management of seizures in the elderly with dementia. First, the presence of cognitive impairment may impede an accurate diagnosis of seizures. Clinicians may also mistake seizure manifestations for symptoms of the underlying dementia. Second, since most dementia patients are elderly, there are pharmacokinetic changes with aging that affect the use of antiepileptic drugs. Third, antiepileptic drugs have potential cognitive adverse effects that may worsen dementia. Although few studies are available, extrapolations from research in young people and elderly patients without dementia provide several recommendations for the management of seizures in patients with dementia: exclude symptomatic causes of seizures before committing to antiepileptic drug therapy; treat after a first seizure if there is evidence of focal neurological involvement or a risk of recurrent seizures; use antiepileptic drugs with minimal cognitive adverse effects, such as carbamazepine, valproic acid, gabapentin and lamotrigine; and use the lowest possible dosage and monitor antiepileptic drug levels, where possible.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12964886     DOI: 10.2165/00002512-200320110-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  93 in total

1.  Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross sectional study.

Authors:  H Jokeit; A Ebner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

Review 2.  Education and the prevalence of dementia and Alzheimer's disease.

Authors:  R Katzman
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

3.  Severe dementia. Prevalence and clinical features in a biracial US population.

Authors:  B S Schoenberg; D W Anderson; A F Haerer
Journal:  Arch Neurol       Date:  1985-08

4.  Risk of recurrent seizures after two unprovoked seizures.

Authors:  W A Hauser; S S Rich; J R Lee; J F Annegers; V E Anderson
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

Review 5.  Neuropsychological effects of epilepsy and antiepileptic drugs.

Authors:  P Kwan; M J Brodie
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

6.  Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975.

Authors:  E Kokmen; C M Beard; K P Offord; L T Kurland
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

Review 7.  The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients.

Authors:  S K Inouye
Journal:  Am J Med       Date:  1994-09       Impact factor: 4.965

8.  A survey of epileptic disorders in southwest France: seizures in elderly patients.

Authors:  J Loiseau; P Loiseau; B Duché; M Guyot; J F Dartigues; B Aublet
Journal:  Ann Neurol       Date:  1990-03       Impact factor: 10.422

9.  Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study.

Authors:  L Forsgren; G Bucht; S Eriksson; L Bergmark
Journal:  Epilepsia       Date:  1996-03       Impact factor: 5.864

10.  Seizures in patients receiving concomitant antimuscarinics and acetylcholinesterase inhibitor.

Authors:  L T Piecoro; D P Wermeling; F A Schmitt; J W Ashford
Journal:  Pharmacotherapy       Date:  1998 Sep-Oct       Impact factor: 4.705

View more
  55 in total

Review 1.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

2.  Vulnerable Patients and Potential Harms: The Contribution of Observational Research.

Authors:  Deborah Layton
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

Review 3.  Epilepsy in elderly people.

Authors:  Martin J Brodie; Patrick Kwan
Journal:  BMJ       Date:  2005-12-03

4.  Seizures and epileptiform activity in the early stages of Alzheimer disease.

Authors:  Keith A Vossel; Alexander J Beagle; Gil D Rabinovici; Huidy Shu; Suzee E Lee; Georges Naasan; Manu Hegde; Susannah B Cornes; Maya L Henry; Alexandra B Nelson; William W Seeley; Michael D Geschwind; Maria L Gorno-Tempini; Tina Shih; Heidi E Kirsch; Paul A Garcia; Bruce L Miller; Lennart Mucke
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

Review 5.  New-onset epilepsy in the elderly.

Authors:  Lily Chi Vu; Loretta Piccenna; Patrick Kwan; Terence J O'Brien
Journal:  Br J Clin Pharmacol       Date:  2018-07-28       Impact factor: 4.335

6.  Evaluation of clinical features of elderly epilepsy in China.

Authors:  Hui-Jun Tian; Xiang-Qing Wang; Xiao-Bing Shi; Sen-Yang Lang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 7.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

8.  Soy-based diet exacerbates seizures in mouse models of neurological disease.

Authors:  Cara J Westmark; Pamela R Westmark; James S Malter
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  BACE1 regulates voltage-gated sodium channels and neuronal activity.

Authors:  Doo Yeon Kim; Bryce W Carey; Haibin Wang; Laura A M Ingano; Alexander M Binshtok; Mary H Wertz; Warren H Pettingell; Ping He; Virginia M-Y Lee; Clifford J Woolf; Dora M Kovacs
Journal:  Nat Cell Biol       Date:  2007-06-18       Impact factor: 28.824

10.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.

Authors:  Keith A Vossel; Kamalini G Ranasinghe; Alexander J Beagle; Danielle Mizuiri; Susanne M Honma; Anne F Dowling; Sonja M Darwish; Victoria Van Berlo; Deborah E Barnes; Mary Mantle; Anna M Karydas; Giovanni Coppola; Erik D Roberson; Bruce L Miller; Paul A Garcia; Heidi E Kirsch; Lennart Mucke; Srikantan S Nagarajan
Journal:  Ann Neurol       Date:  2016-11-07       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.